Literature DB >> 28820187

Cerebral venous thrombosis.

Suzanne M Silvis1, Diana Aguiar de Sousa2, José M Ferro2, Jonathan M Coutinho1.   

Abstract

Cerebral venous thrombosis (CVT) is an important cause of stroke in young adults. Data from large international registries published in the past two decades have greatly improved our knowledge about the epidemiology, clinical manifestations and prognosis of CVT. The presentation of symptoms is highly variable in this disease, and can range from a patient seen at the clinic with a 1-month history of headache, to a comatose patient admitted to the emergency room. Consequently, the diagnosis of CVT is often delayed or overlooked. A variety of therapies for CVT are available, and each should be used in the appropriate setting, preferably guided by data from randomized trials and well-designed cohort studies. Although deaths from CVT have decreased in the past few decades, mortality remains ∼5-10%. In this Review, we provide a comprehensive and contemporary overview of CVT in adults, with emphasis on advancements made in the past decade on the epidemiology and treatment of this multifaceted condition.

Entities:  

Mesh:

Year:  2017        PMID: 28820187     DOI: 10.1038/nrneurol.2017.104

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  145 in total

1.  Direct thrombolytic therapy for superior sagittal sinus thrombosis.

Authors:  R T Higashida; E Helmer; V V Halbach; G B Hieshima
Journal:  AJNR Am J Neuroradiol       Date:  1989 Sep-Oct       Impact factor: 3.825

Review 2.  Cerebral venous thrombosis.

Authors:  J M Coutinho
Journal:  J Thromb Haemost       Date:  2015-06       Impact factor: 5.824

3.  Long-term evaluation of the risk of recurrence after cerebral sinus-venous thrombosis.

Authors:  Ida Martinelli; Paolo Bucciarelli; Serena M Passamonti; Tullia Battaglioli; Emanuele Previtali; Pier Mannuccio Mannucci
Journal:  Circulation       Date:  2010-06-14       Impact factor: 29.690

4.  Impact of anatomical difference of the cerebral venous system on microcirculation in a gerbil superior sagittal sinus occlusion model.

Authors:  K Ueda; H Nakase; K Miyamoto; H Otsuka; T Sakaki
Journal:  Acta Neurochir (Wien)       Date:  2000       Impact factor: 2.216

5.  Parenchymal abnormalities associated with cerebral venous sinus thrombosis: assessment with diffusion-weighted MR imaging.

Authors:  Mark E Mullins; P Ellen Grant; Bing Wang; R Gilberto Gonzalez; Pamela W Schaefer
Journal:  AJNR Am J Neuroradiol       Date:  2004 Nov-Dec       Impact factor: 3.825

Review 6.  Thrombolytics for cerebral sinus thrombosis: a systematic review.

Authors:  Patricia Canhão; Filipa Falcão; José M Ferro
Journal:  Cerebrovasc Dis       Date:  2003       Impact factor: 2.762

7.  Cerebral vein and dural sinus thrombosis in elderly patients.

Authors:  José M Ferro; Patrícia Canhão; Marie-Germaine Bousser; Jan Stam; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2005-08-11       Impact factor: 7.914

8.  Superior Sagittal Sinus Thrombosis.

Authors:  D M Gettelfinger; E Kokmen
Journal:  Arch Neurol       Date:  1977-01

9.  Long-term sequelae after cerebral venous thrombosis in functionally independent patients.

Authors:  Karen Koopman; Maarten Uyttenboogaart; Patrick C Vroomen; Jan van der Meer; Jacques De Keyser; Gert-Jan Luijckx
Journal:  J Stroke Cerebrovasc Dis       Date:  2009 May-Jun       Impact factor: 2.136

Review 10.  Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young.

Authors:  E Steve Roach; Meredith R Golomb; Robert Adams; Jose Biller; Stephen Daniels; Gabrielle Deveber; Donna Ferriero; Blaise V Jones; Fenella J Kirkham; R Michael Scott; Edward R Smith
Journal:  Stroke       Date:  2008-07-17       Impact factor: 7.914

View more
  65 in total

1.  [Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination].

Authors: 
Journal:  Neurologia       Date:  2021-05-06       Impact factor: 3.109

2.  Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT).

Authors:  Philip Connor; Mayte Sánchez van Kammen; Anthonie W A Lensing; Elizabeth Chalmers; Krisztián Kállay; Kerry Hege; Paolo Simioni; Tina Biss; Fanny Bajolle; Damien Bonnet; Sebastian Grunt; Riten Kumar; Olga Lvova; Rukhmi Bhat; An Van Damme; Joseph Palumbo; Amparo Santamaria; Paola Saracco; Jeanette Payne; Susan Baird; Kamar Godder; Veerle Labarque; Christoph Male; Ida Martinelli; Michelle Morales Soto; Jayashree Motwani; Sanjay Shah; Helene L Hooimeijer; Martin H Prins; Dagmar Kubitza; William T Smith; Scott D Berkowitz; Akos F Pap; Madhurima Majumder; Paul Monagle; Jonathan M Coutinho
Journal:  Blood Adv       Date:  2020-12-22

Review 3.  Cerebral Venous Thrombosis: an Update.

Authors:  José M Ferro; Diana Aguiar de Sousa
Journal:  Curr Neurol Neurosci Rep       Date:  2019-08-23       Impact factor: 5.081

4.  Effect of Endovascular Treatment With Medical Management vs Standard Care on Severe Cerebral Venous Thrombosis: The TO-ACT Randomized Clinical Trial.

Authors:  Jonathan M Coutinho; Susanna M Zuurbier; Marie-Germaine Bousser; Xunming Ji; Patricia Canhão; Yvo B Roos; Isabelle Crassard; Ana Paiva Nunes; Maarten Uyttenboogaart; Jian Chen; Bart J Emmer; Stefan D Roosendaal; Emmanuel Houdart; Jim A Reekers; René van den Berg; Rob J de Haan; Charles B Majoie; José M Ferro; Jan Stam
Journal:  JAMA Neurol       Date:  2020-08-01       Impact factor: 18.302

Review 5.  Nontraumatic intracerebral haemorrhage in young adults.

Authors:  Turgut Tatlisumak; Brett Cucchiara; Satoshi Kuroda; Scott E Kasner; Jukka Putaala
Journal:  Nat Rev Neurol       Date:  2018-03-09       Impact factor: 42.937

6.  Trends in incidence and epidemiologic characteristics of cerebral venous thrombosis in the United States.

Authors:  Fadar Oliver Otite; Smit Patel; Richa Sharma; Pushti Khandwala; Devashish Desai; Julius Gene Latorre; Emmanuel Oladele Akano; Nnabuchi Anikpezie; Saef Izzy; Amer M Malik; Dileep Yavagal; Priyank Khandelwal; Seemant Chaturvedi
Journal:  Neurology       Date:  2020-08-26       Impact factor: 9.910

7.  Diffusion-Weighted Magnetic Resonance Imaging in the Diagnosis of Cerebral Venous Thrombosis : A Meta-Analysis.

Authors:  Bin Lv; Feng Jing; Cheng-Lin Tian; Jian-Chao Liu; Jun Wang; Xiang-Yu Cao; Xin-Feng Liu; Sheng-Yuan Yu
Journal:  J Korean Neurosurg Soc       Date:  2021-04-30

8.  Cerebral venous thrombosis: a retrospective unicentric analysis of clinical and neuroimaging characteristics.

Authors:  Jovan Petrović; Tamara Švabić; Jasna Zidverc-Trajković; Predrag Stanarčević; Dejana Jovanović; Milija Mijajlović
Journal:  Neurol Sci       Date:  2021-08-04       Impact factor: 3.307

9.  A Novel Mouse Model for Cerebral Venous Sinus Thrombosis.

Authors:  Marie-Charlotte Bourrienne; Stéphane Loyau; Sandro Benichi; Juliette Gay; Mialitiana Solo-Nomenjanahary; Clément Journé; Lucas Di Meglio; Aurélien Freiherr von Seckendorff; Jean-Philippe Desilles; Benoît Ho-Tin-Noé; Nadine Ajzenberg; Mikaël Mazighi
Journal:  Transl Stroke Res       Date:  2021-03-05       Impact factor: 6.829

10.  Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination.

Authors: 
Journal:  Neurologia (Engl Ed)       Date:  2021-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.